Short-course Radiotherapy Followed by Consolidation Chemotherapy. 2021-001206-29

NCT05253846 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

63

Enrollment

OTHER

Sponsor class

Conditions

Locally Advanced Rectal Cancer

Interventions

DRUG: Irinotecan
DRUG: Oxaliplatin
DRUG: Lederfolin
DRUG: 5-Fluorouracil
RADIATION: Short-course radiotherapy
PROCEDURE: TME

Sponsor

Gruppo Oncologico del Nord-Ovest